Literature DB >> 2299973

Opioid-dependent growth of glial cultures: suppression of astrocyte DNA synthesis by met-enkephalin.

A Stiene-Martin1, K F Hauser.   

Abstract

The action of met-enkephalin on the growth of astrocytes in mixed-glial cultures was examined. Primary, mixed-glial cultures were isolated from 1 day-old mouse cerebral hemispheres and continuously treated with either basal growth media (controls), 1 microM met-enkephalin, 1 microM met-enkephalin plus the opioid antagonist naloxone (3 microM), or naloxone alone (3 microM). Absolute numbers of neural cells were counted in unstained preparations, while combined [3H]-thymidine autoradiography and glial fibrillary acid protein (GFAP) immunocytochemistry was performed to identify specific changes in astrocytes. When compared to control and naloxone treated cultures, met-enkephalin caused a significant decrease in both total cell numbers, and in [3H]-thymidine incorporation by GFAP-positive cells with flat morphology. These results indicate that met-enkephalin suppresses astrocyte growth in culture.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2299973     DOI: 10.1016/0024-3205(90)90041-o

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  19 in total

1.  Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation.

Authors:  Fan Cheng; Patricia J McLaughlin; William A Banks; Ian S Zagon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-30       Impact factor: 3.619

2.  kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids.

Authors:  J A Gurwell; M J Duncan; K Maderspach; A Stiene-Martin; R P Elde; K F Hauser
Journal:  Brain Res       Date:  1996-10-21       Impact factor: 3.252

Review 3.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

4.  Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro.

Authors:  A Stiene-Martin; K F Hauser
Journal:  J Neurosci Res       Date:  1991-08       Impact factor: 4.164

5.  Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes.

Authors:  A Stiene-Martin; R Zhou; K F Hauser
Journal:  Glia       Date:  1998-03       Impact factor: 7.452

6.  Cellular localization of proenkephalin mRNA and enkephalin peptide products in cultured astrocytes.

Authors:  K F Hauser; J G Osborne; A Stiene-Martin; M H Melner
Journal:  Brain Res       Date:  1990-07-09       Impact factor: 3.252

7.  Dynorphins modulate DNA synthesis in fetal brain cell aggregates.

Authors:  A Gorodinsky; J Barg; M M Belcheva; R Levy; R J McHale; Z Vogel; C J Coscia
Journal:  J Neurochem       Date:  1995-10       Impact factor: 5.372

8.  Differential effects of methionine enkephalin on the growth of brain tumor cells.

Authors:  Y S Lee; R D Wurster
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Chronic treatment of newborn rats with naltrexone alters astrocyte production of nerve growth factor.

Authors:  K Mitsuo; J P Schwartz
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

10.  Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.

Authors:  S K Buch; V K Khurdayan; S E Lutz; P E Knapp; N El-Hage; K F Hauser
Journal:  Neuroscience       Date:  2007-05-02       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.